Original Research

Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria

Kome Otokunefor, Tosanwumi V. Otokunefor, Godwin Omakwele
African Journal of Laboratory Medicine | Vol 7, No 2 | a805 | DOI: https://doi.org/10.4102/ajlm.v7i2.805 | © 2018 Kome Otokunefor, Tosanwumi V. Otokunefor, Godwin Omakwele | This work is licensed under CC Attribution 4.0
Submitted: 21 March 2018 | Published: 06 December 2018

About the author(s)

Kome Otokunefor, Department of Microbiology, Faculty of Science, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria
Tosanwumi V. Otokunefor, Department of Microbiology, Faculty of Science, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria
Godwin Omakwele, Department of Microbiology, Faculty of Science, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria

Abstract

Background: In past years, much focus has been on tackling the scourge and spread of tuberculosis worldwide. The recent emergence of multi-drug resistant (MDR) tuberculosis has, however, negatively threatened progress made so far. Nigeria ranks fourth out of the 22 high tuberculosis burden countries in the world and has the highest burden of tuberculosis in Africa. It is therefore necessary to monitor the MDR tuberculosis situation in the country.

Objectives: This study set out to assess the proportions of MDR tuberculosis in patients attending six directly observed treatment short-course centres in Port Harcourt, Nigeria, from October 2015 to October 2016.

Methods: Six hundred and nine participants between the ages of 18 and 75 years were enrolled in this study and comprised suspected and newly diagnosed tuberculosis cases. Sputum samples obtained from the participants were screened for the presence of Mycobacterium tuberculosis using standard culture and phenotypic biochemical techniques, and drug susceptibility testing was carried out using the 1% proportion conventional method.

Results: Of the 609 participants enrolled, 30 (4.9%) were confirmed as M. tuberculosis-positive cases. A high prevalence of drug resistant tuberculosis was noted in this study (14/30, 46.7%), with 26.7% of isolates resistant to streptomycin. MDR tuberculosis, defined as being resistant to isoniazid and rifampicin, was detected in only one case (3.3%).

Conclusion: This study reports a low rate of MDR tuberculosis and contributes to the sparse data on drug resistant tuberculosis in Nigeria.


Keywords

Tuberculosis; Nigeria; MDR; New cases; Resistance

Metrics

Total abstract views: 5423
Total article views: 8523

 

Crossref Citations

1. Patterns of resistance to first-line anti-Tuberculosis drugs among patients in Abuja, Nigeria: 2009-2012
Chukwuemeka Anthonia
Journal of Interventional Epidemiology and Public Health  vol: 7  issue: 1  year: 2024  
doi: 10.37432/jieph.2024.7.1.96

2. Revolutionizing Antibiotic Delivery: Harnessing 3D-Printing Technology to Combat Bacterial Resistance
Shubham Singh, Mohit Kumar, Deeksha Choudhary, Dikshant, Devesh Kumar, Shruti Chopra, Amit Bhatia
Current Pharmaceutical Design  vol: 32  issue: 2  first page: 115  year: 2025  
doi: 10.2174/0113816128365632250524160128

3. Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis
Anita Svadzian, Giorgia Sulis, Genevieve Gore, Madhukar Pai, Claudia M Denkinger
BMJ Global Health  vol: 5  issue: 10  first page: e003438  year: 2020  
doi: 10.1136/bmjgh-2020-003438

4. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis
Nader Salari, Amir Hossein Kanjoori, Amin Hosseinian-Far, Razie Hasheminezhad, Kamran Mansouri, Masoud Mohammadi
Infectious Diseases of Poverty  vol: 12  issue: 1  year: 2023  
doi: 10.1186/s40249-023-01107-x

5. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria
Gbadebo J. Oyedeji, Charles Adeyemo, Affolabi Dissou, Tope Abiodun, Oyebode A.T. Alli, Olakunle J. Onaolapo, Adejoke Y. Onaolapo, Yemisi Adesiji, Olugbenga A. Olowe
Current Pharmaceutical Biotechnology  vol: 21  issue: 10  first page: 939  year: 2020  
doi: 10.2174/1389201021666200226100242

6. Roles and challenges of clinical microbiology laboratories in antimicrobial stewardship in resource-limited countries
Mohammed Ibrahim Tahir, Abdurrahman El-Fulaty Ahmad, Temidayo Oluwafemi Ige, Idris Nasir Abdullahi, Yahaya Usman, Ahmed Babangida Suleiman
Journal of Clinical Sciences  vol: 18  issue: 2  first page: 74  year: 2021  
doi: 10.4103/jcls.jcls_60_19

7. Gene mutation patterns of Mycobacterium tuberculosis complex and associated factors among suspected multidrug-resistant tuberculosis patients in Osun State, South-West, Nigeria
Onaiwu T. Ohiengbomwan, Judith Oguzie, Philomena Eromon, Adeyemi T. Kayode, Taofeek Sola Afolabi, Isaac O. Komolafe
Scientific African  vol: 22  first page: e01968  year: 2023  
doi: 10.1016/j.sciaf.2023.e01968

8. Trends of Xpert MTB/RIF in the diagnosis of Mycobacterium tuberculosis and rifampicin resistance in Southwest Nigeria: A 4-year retrospective study
Michael Abel Alao, Olayinka Rasheed Ibrahim, Babatunde Oluwatosin Ogunbosi
Journal of the Pan African Thoracic Society  vol: 4  first page: 31  year: 2022  
doi: 10.25259/JPATS_25_2022